Union Bancaire Privee UBP SA Makes New $635,000 Investment in Agilent Technologies, Inc. $A

Union Bancaire Privee UBP SA bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,760 shares of the medical research company’s stock, valued at approximately $635,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. SHP Wealth Management purchased a new position in Agilent Technologies during the 4th quarter worth approximately $26,000. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at approximately $26,000. Board of the Pension Protection Fund acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $27,000. Navalign LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $27,000. Finally, MV Capital Management Inc. purchased a new position in shares of Agilent Technologies during the fourth quarter worth approximately $28,000.

Agilent Technologies Stock Performance

Shares of A opened at $136.29 on Monday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market capitalization of $38.49 billion, a P/E ratio of 27.37, a P/E/G ratio of 2.42 and a beta of 1.26. The company’s fifty day moving average is $122.86 and its two-hundred day moving average is $126.21. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, strengthening its diagnostics and clinical pathology offerings and potentially improving long-term growth prospects. Agilent finalizes Biocare Medical takeover
• Positive Sentiment: Sanford C. Bernstein initiated coverage with an outperform rating and a $155 price target, which may bolster investor confidence in additional share price upside. Benzinga coverage
• Positive Sentiment: Recent commentary highlights Agilent’s post-earnings resilience, reflecting steady investor interest after the company beat expectations and raised/confirmed guidance. Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
• Neutral Sentiment: Piper Sandler initiated coverage at Neutral with a $150 target, which is supportive but less bullish than Bernstein’s call. Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
• Neutral Sentiment: Articles about dividend reliability and broader adoption of Agilent software suggest steady fundamentals, but they are less likely to drive a major near-term stock move. Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? Shanghai ICRD Adopts Agilent Software
• Neutral Sentiment: Agilent’s stock has been trading with modest strength following the earnings release, but the move appears tied more to execution and sentiment than to any single dramatic catalyst. Agilent (A) stock trades up, here is why

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. TD Cowen increased their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. HSBC decreased their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Barclays boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $160.88.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.